| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2432776A1 Isoindolyl and isoquinolinyl aroyl pyrrole compounds |
| 07/25/2002 | CA2432041A1 Polynucleotides encoding human phosphatases |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | CA2430577A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 07/25/2002 | CA2427058A1 Substituted felbamate derived compounds |
| 07/25/2002 | CA2426775A1 Thienopyrimidine-based inhibitors of the src family |
| 07/25/2002 | CA2425125A1 Method of treating parkinson's disease |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1225174A1 Anhydrous mirtazapine crystals and process for the production thereof |
| 07/24/2002 | EP1225170A2 Cycloheptene compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/24/2002 | EP1224941A2 Antithrombin III used in diseases caused by angiogenesis |
| 07/24/2002 | EP1224938A1 Gugulipid for treating cognitive disorders, hyperglycaemia and skin disorders |
| 07/24/2002 | EP1224932A1 Drugs inhibiting cell death |
| 07/24/2002 | EP1224930A1 Combination of a SR inhibitor and sigma receptor ligand in the treatment ofdepression |
| 07/24/2002 | EP1224861A1 Animal with the mass expression of human gene and test method by using the animal |
| 07/24/2002 | EP1224471A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 07/24/2002 | EP1224469A1 Method of screening for inhibitors of asp2 |
| 07/24/2002 | EP1224322A2 Gene sequence variations with utility in determining the treatment of disease |
| 07/24/2002 | EP1224320A1 Method of screening for inhibitors of asp1 |
| 07/24/2002 | EP1224314A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 07/24/2002 | EP1224291A1 Multiple sclerosis-related superantigen |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | EP1224212A1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224208A1 Human inwardly rectifying potassium channel subunit |
| 07/24/2002 | EP1224207A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 07/24/2002 | EP1224206A1 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 07/24/2002 | EP1224205A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224188A2 A salt of morphine |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224182A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224173A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 07/24/2002 | EP1224163A1 Use of carbonylamino derivatives against cns disorders |
| 07/24/2002 | EP1224160A1 Polymorphic forms of sertraline hydrochloride |
| 07/24/2002 | EP1224155A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223973A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 07/24/2002 | EP1223969A2 Combined use of a plasminogen activator and il-2 inhibitors for neuroprotection |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223946A1 Human neuropeptide receptor |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223939A1 Method of treating weight gain |
| 07/24/2002 | EP1223938A1 TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/$g(a) 2? ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS |
| 07/24/2002 | EP1223937A2 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223930A1 Treatment of dyskinesia |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223927A2 Use of retigabin for treating neuropathic pain |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1223914A2 Orally distintegrating composition comprising mirtazapine |
| 07/24/2002 | EP1100767B1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 07/24/2002 | EP1022960B1 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects |
| 07/24/2002 | EP0983268B1 Amidine derivatives as inhibitors of nitric oxide synthase |
| 07/24/2002 | EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 07/24/2002 | EP0922034B1 Tetrahydroquinoline derivatives as eaa antagonists |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/24/2002 | EP0820454B1 Anellated beta-carbolines |
| 07/24/2002 | EP0693070B1 PYRIDO[2,3-b](1,4)BENZODIAZEPINONES AS M2 RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 07/24/2002 | EP0664832B1 Remyelination using neural stem cells |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360591A 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360571A Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. |
| 07/24/2002 | CN1360570A Phenyl sulfamate derivs. |
| 07/24/2002 | CN1360501A Treatment of neurotic disorders |
| 07/24/2002 | CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 07/24/2002 | CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360020A Wine for giving off smoking |
| 07/24/2002 | CN1359703A Oral liquid for detoxicating and dispelling wind |
| 07/24/2002 | CN1359684A Pharmaceutical composition for giving up smoking |
| 07/24/2002 | CN1359679A Medicine for dropping off drug and its preparing process |
| 07/24/2002 | CN1088064C Naphthoxazines derivs., process for their preparation and pharmaceutical compositions contg. them |
| 07/24/2002 | CN1088062C Certain 4-aminomethy-2-substd. imidazole derivs. and 2-aminomethyl-4-substd. imidazole derivs. new classes of dopamine receptor subtype specific ligands |
| 07/24/2002 | CN1087952C Method for producing medicine for curing vertigo |
| 07/24/2002 | CN1087947C 'Shencaosanye' tea |
| 07/24/2002 | CN1087943C Stable extract of hyperricum perforatum, process for preparing same and pharmaceutical compositions |
| 07/24/2002 | CN1087937C Medicine of inhibiting Alzheimer's disease |
| 07/24/2002 | CN1087936C Use of thiadiazole and oxadiazole derivs. in preparing antipsychotic medicine |
| 07/23/2002 | US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/23/2002 | US6423842 Act preferentially on m4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; alzheimer's disease; cognition activators. |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423739 Method for aiding cerebral recovery following neurodegeneration |
| 07/23/2002 | US6423725 Analgesics |
| 07/23/2002 | US6423717 Nervous system disorders |